The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies

Neuroscience and Biobehavioral Reviews

Volumn 56, Issue , 2015, Pages 26-34

  Grimonprez, Annelies ^a   Raedt, Robrecht ^a   Baeken, Chris ^a,b   Boon, Paul ^a   Vonck, Kristl ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Major depressive disorder; The monoaminergic hypothesis of major depressive disorder; The neural plasticity hypothesis of major depressive disorder; Vagus nerve stimulation

Indexed keywords

MONOAMINE; NORADRENALIN; SEROTONIN;

BRAIN DEPTH STIMULATION; BRAIN REGION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; EVIDENCE BASED MEDICINE; HUMAN; MAJOR DEPRESSION; MONOAMINERGIC SYSTEM; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEURAL STEM CELL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNAPTOGENESIS; THERAPY EFFECT; VAGUS NERVE STIMULATION; ANIMAL; BRAIN; DEPRESSION; PHYSIOLOGY; PROCEDURES; TRANSLATIONAL RESEARCH;

ANIMALS; BRAIN; DEPRESSION; HUMANS; NEURONAL PLASTICITY; TRANSLATIONAL MEDICAL RESEARCH; VAGUS NERVE STIMULATION;

EID: 84947260674     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.06.019     Document Type: Review

References (130)

1. Aaronson S.T., et al. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul. 2013, 6(4):631-640.
2. Alonso J., et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr. Scand. Suppl. 2004, 420:21-27.
3. Andresen M.C., Kunze D.L. Nucleus tractus solitarius - gateway to neural circulatory control. Annu. Rev. Physiol. 1994, 56:93-116.
4. Aston-Jones G., et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res. 1991, 88:47-75.
5. Aston-Jones G., Zhu Y., Card J.P. Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J. Neurosci. 2004, 24(9):2313-2321.
6. Bajbouj M., et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J. Clin. Psychopharmacol 2010, 30(3):273-281.
7. Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 1980, 19(4):355-363.
8. Belzung C., Willner P., Philippot P. Depression: from psychopathology to pathophysiology. Curr. Opin. Neurobiol. 2015, 30:24-30.
9. Benkelfat C., et al. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch. Gen. Psychiatry 1994, 51(9):687-697.
10. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002, 1(8):477-482.
11. Berlim M.T., Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can. J. Psychiatry 2007, 52(1):46-54.
12. Berry S.M., et al. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med. Devices (Auckl.) 2013, 6:17-35.
13. Biggio F., et al. Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. Int. J. Neuropsychopharmacol. 2009, 12(9):1209-1221.
14. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur. Neuropsychopharmacol. 2003, 13(2):57-66.
15. Bremner J.D., et al. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157(1):115-118.
16. Brezun J.M., Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999, 89(4):999-1002.
17. Carpenter L.L., et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998, 19(1):26-35.
18. Cedarbaum J.M., Aghajanian G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 1978, 178(1):1-16.
19. Chadi G., et al. Basic fibroblast growth factor (bFGF, FGF-2) immunoreactivity exists in the noradrenaline, adrenaline and 5-HT nerve cells of the rat brain. Neurosci. Lett. 1993, 160(2):171-176.
20. Chen B., et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50(4):260-265.
21. Chen M.J., et al. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell. Signal. 2007, 19(1):114-128.
22. Clark K.B., et al. Post-training unilateral vagal stimulation enhances retention performance in the rat. Neurobiol. Learn. Mem. 1995, 63(3):213-216.
23. Clark K.B., et al. Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes in the rat. Neurobiol. Learn. Mem. 1998, 70(3):364-373.
24. Clark K.B., et al. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat. Neurosci. 1999, 2(1):94-98.
25. Conway C.R., et al. Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder. Brain Stimul. 2012, 5(2):163-171.
26. Conway C.R., et al. Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression. Brain Stimul. 2013, 6(5):788-797.
27. Cristancho P., et al. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J. Clin. Psychiatry 2011, 72(10):1376-1382.
28. Cunningham J.T., et al. Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology 2008, 33(8):1884-1895.
29. Dorr A.E., Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 2006, 318(2):890-898.
30. Duman R.S. Depression: a case of neuronal life and death?. Biol. Psychiatry 2004, 56(3):140-145.
31. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001, 25(6):836-844.
32. Elger G., et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 2000, 42(2-3):203-210.
33. Ennis M., Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J. Neurosci. 1988, 8(10):3644-3657.
34. Ennis M., Aston-Jones G. GABA-mediated inhibition of locus coeruleus from the dorsomedial rostral medulla. J. Neurosci. 1989, 9(8):2973-2981.
35. Eriksson P.S., et al. Neurogenesis in the adult human hippocampus. Nat. Med. 1998, 4(11):1313-1317.
36. Florin-Lechner S.M., et al. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res. 1996, 742(1-2):89-97.
37. Follesa P., et al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res. 2007, 1179:28-34.
38. Fuchs E., Czeh B., Flugge G. Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. Behav. Pharmacol. 2004, 15(5-6):315-325.
39. Furmaga H., Carreno F.R., Frazer A. Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLOS ONE 2012, 7(5):e34844.
40. Gebhardt N., et al. Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats. Brain Stimul. 2013, 6(1):78-83.
41. George M.S., et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol. Psychiatry 2005, 58(5):364-373.
42. Gieroba Z.J., Blessing W.W. Fos-containing neurons in medulla and pons after unilateral stimulation of the afferent abdominal vagus in conscious rabbits. Neuroscience 1994, 59(4):851-858.
43. Glaum S.R., Miller R.J. Metabotropic glutamate receptors depress afferent excitatory transmission in the rat nucleus tractus solitarii. J. Neurophysiol. 1993, 70(6):2669-2672.
44. Grimonprez A., et al. Vagus nerve stimulation has antidepressant effects in the kainic acid model for temporal lobe epilepsy. Brain Stimul. 2014, 8:13-20.
45. Grimonprez A., Raedt R., Portelli J., Dauwe I., Lars Emil Larsen, Bouckaert C., Delbeke J., Carrette E., Meurs A., De Herdt V., Boon P., Vonck K. The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus. J. Psychiatr. Res. 2015, (Accepted for publication).
46. Gronli J., et al. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol. Behav. 2005, 84(4):571-577.
47. Groves J.O. Is it time to reassess the BDNF hypothesis of depression?. Mol. Psychiatry 2007, 12(12):1079-1088.
48. Groves D.A., Bowman E.M., Brown V.J. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci. Lett. 2005, 379(3):174-179.
49. Hanson N.D., Owens M.J., Nemeroff C.B. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011, 36(13):2589-2602.
50. Harden C.L. Depression and anxiety in epilepsy patients. Epilepsy Behav. 2002, 3(3):296.
51. Hassert D.L., Miyashita T., Williams C.L. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav. Neurosci. 2004, 118(1):79-88.
52. He W., et al. The auriculo-vagal afferent pathway and its role in seizure suppression in rats. BMC Neurosci. 2013, 14:85.
53. Henry T.R. Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002, 59(6 Suppl. 4):S3-S14.
54. Holtzheimer P.E., Mayberg H.S. Neuromodulation for treatment-resistant depression. F1000 Med. Rep. 2012, 4:22.
55. Ibanez C.F. Neurotrophic factors: from structure-function studies to designing effective therapeutics. Trends Biotechnol. 1995, 13(6):217-227.
56. Jayatissa M.N., et al. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 2006, 31(11):2395-2404.
57. Jayatissa M.N., et al. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008, 54(3):530-541.
58. Jayatissa M.N., et al. Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats. Brain Res. 2009, 1290:133-141.
59. Jhaveri D.J., et al. Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J. Neurosci. 2010, 30(7):2795-2806.
60. Kanner A.M. The complex epilepsy patient: intricacies of assessment and treatment. Epilepsia 2003, 44(Suppl. 5):3-8.
61. Kanner A.M. Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders?. Lancet Neurol. 2012, 11(12):1093-1102.
62. Kanner A.M., Balabanov A. Depression and epilepsy: how closely related are they?. Neurology 2002, 58(8 Suppl. 5):S27-S39.
63. Karege F., et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109(2):143-148.
64. Karege F., et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 2005, 57(9):1068-1072.
65. Kessler R.C. Epidemiology of women and depression. J. Affect. Disord. 2003, 74(1):5-13.
66. Kihara M., Kubo T. Immunocytochemical localization of glutamate containing neurons in the ventrolateral medulla oblongata and the nucleus tractus solitarius of the rat. J. Hirnforsch. 1991, 32(1):113-118.
67. Klinkenberg S., et al. Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy. Clin. Neurol. Neurosurg. 2012, 114(4):336-340.
68. Knott V.J., et al. The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects. Biol. Psychiatry 1999, 46(2):229-238.
69. Kosel M., et al. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Res. 2011, 191(3):153-159.
70. Krahl S.E. Vagus nerve stimulation for epilepsy: a review of the peripheral mechanisms. Surg. Neurol. Int. 2012, 3(Suppl. 1):S47-S52.
71. Krahl S.E., et al. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J. Psychiatr. Res. 2004, 38(3):237-240.
72. Kulkarni V.A., Jha S., Vaidya V.A. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur. J. Neurosci. 2002, 16(10):2008-2012.
73. Landau A.M., Dyve S., Jakobsen S., Alstrup A.K.O., Gjedde A., Doudet D.J. Acute vagal nerve stimulation lowers α2 adrenoceptor occupancy: possible mechanism of therapeutic action. Brain Stimul. 2015, (in press).
74. Leger L., Descarries L. Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study. Brain Res. 1978, 145(1):1-13.
75. Lehmann K., Butz M., Teuchert-Noodt G. Offer and demand: proliferation and survival of neurons in the dentate gyrus. Eur. J. Neurosci. 2005, 21(12):3205-3216.
76. Liu Z., Chen C.Y., Bonham A.C. Metabotropic glutamate receptors depress vagal and aortic baroreceptor signal transmission in the NTS. Am. J. Physiol. 1998, 275(5 Pt 2):H1682-H1694.
77. Loy R., et al. Noradrenergic innervation of the adult rat hippocampal formation. J. Comp. Neurol. 1980, 189(4):699-710.
78. Malberg J.E., et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20(24):9104-9110.
79. Mallei A., Shi B., Mocchetti I. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol. Pharmacol. 2002, 61(5):1017-1024.
80. Manta S., et al. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. J. Psychiatry Neurosci. 2009, 34(4):272-280.
81. Manta S., et al. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int. J. Neuropsychopharmacol. 2012, 1-12.
82. Manta S., et al. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. Int. J. Neuropsychopharmacol. 2013, 16(2):459-470.
83. Marangell L.B., et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol. Psychiatry 2002, 51(4):280-287.
84. Maximino C., Herculano A.M. A review of monoaminergic neuropsychopharmacology in zebrafish. Zebrafish 2010, 7(4):359-378.
85. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1999, 22:105-122.
86. Memberg S.P., Hall A.K. Proliferation, differentiation, and survival of rat sensory neuron precursors in vitro require specific trophic factors. Mol. Cell. Neurosci. 1995, 6(4):323-335.
87. Mendlewicz J. Towards achieving remission in the treatment of depression. Dialogues Clin. Neurosci. 2008, 10(4):371-375.
88. Millan M.J. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur. J. Pharmacol. 2004, 500(1-3):371-384.
89. Moret C., Briley M. The importance of norepinephrine in depression. Neuropsychiatr. Dis. Treat. 2011, 7(Suppl. 1):9-13.
90. Muller H.H., et al. The effects of stimulation parameters on clinical outcomes in patients with vagus nerve stimulation implants with major depression. J. ECT 2013, 29(3):e40-e42.
91. Murray C.L., Lopez A.D. The Global Burden of Disease 2001, World Health Organisation, Geneva.
92. Nahas Z., et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J. Clin. Psychiatry 2005, 66(9):1097-1104.
93. Nakagawa S., et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J. Neurosci. 2002, 22(9):3673-3682.
94. Naritoku D.K., Terry W.J., Helfert R.H. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 1995, 22(1):53-62.
95. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15(11):7539-7547.
96. Nierenberg A.A., et al. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol. Psychiatry 2008, 64(6):455-460.
97. Palmer T.D., et al. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci. 1999, 19(19):8487-8497.
98. Park M.C., et al. Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects. Acta Neurochir. Suppl. 2007, 97(Pt 2):407-416.
99. Pineyro G., Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 1999, 51(3):533-591.
100. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266(5604):730-732.
101. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35(1):192-216.
102. Raedt R., et al. Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J. Neurochem. 2011, 117(3):461-469.
103. Rantamaki T., et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 2007, 32(10):2152-2162.
104. Revesz D., et al. Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp. Neurol. 2008, 214(2):259-265.
105. Rizk P., et al. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 2006, 31(6):1146-1157.
106. Roosevelt R.W., et al. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res. 2006, 1119(1):124-132.
107. Ruffoli R., et al. The chemical neuroanatomy of vagus nerve stimulation. J. Chem. Neuroanat. 2011, 42(4):288-296.
108. Rush A.J., et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol. Psychiatry 2000, 47(4):276-286.
109. Rush A.J., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol. Psychiatry 2005, 58(5):347-354.
110. Rush A.J., et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol. Psychiatry 2005, 58(5):355-363.
111. Saarelainen T., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 2003, 23(1):349-357.
112. Sackeim H.A., et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25(5):713-728.
113. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 2007, 10(9):1110-1115.
114. Santarelli L., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301(5634):805-809.
115. Schlaepfer T.E., et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol. Med. 2008, 38(5):651-661.
116. Sheline Y.I., et al. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(9):3908-3913.
117. Shimizu E., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003, 54(1):70-75.
118. Slattery D.A., Cryan J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 2012, 7(6):1009-1014.
119. Sousa N., et al. Erratum to "Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement". Neuroscience 2000, 101(2):483.
120. Svensson T.H., Bunney B.S., Aghajanian G.K. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975, 92(2):291-306.
121. Swartz J.B., Weinreich D. Influence of vagotomy on monosynaptic transmission at second-order nucleus tractus solitarius synapses. J. Neurophysiol. 2009, 102(5):2846-2855.
122. Van Bockstaele E.J., Peoples J., Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J. Comp. Neurol. 1999, 412(3):410-428.
123. van der Hart M.G., et al. Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol. Psychiatry 2002, 7(9):933-941.
124. Vandermaelen C.P., Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 1983, 289(1-2):109-119.
125. Vermetten E., et al. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 2003, 54(7):693-702.
126. Vyas A., et al. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 2002, 22(15):6810-6818.
127. Wainwright S.R., Galea L.A. The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast. 2013, 2013:805497.
128. Wong M.L., Licinio J. Research and treatment approaches to depression. Nat. Rev. Neurosci. 2001, 2(5):343-351.
129. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132(4):645-660.
130. Zuo Y., Smith D.C., Jensen R.A. Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats. Physiol. Behav. 2007, 90(4):583-589.